Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rintala

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Intensive Care Medicine|November 23, 2000
Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcomeE Rintala, H Peuravuori, K Pulkki, et al.
International Journal of Cancer|June 17, 1999
Detection of messenger RNA for the beta-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reactionK Hotakainen, S Lintula, J Stenman, et al.
The Journal of Urology|June 1, 1996
Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study GroupP U Malmström, E Rintala, R Wahlqvist, et al.
Journal of Nephrology|October 2, 2015
Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritisJukka M Rintala, Johanna Savikko, Sini E Rintala, et al.
Urological Research|January 1, 1992
Cytostatic effect of different strains of Bacillus Calmette-Guérin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alphaP Rajala, E Kaasinen, E Rintala, et al.
The Journal of Urology|March 19, 1999
Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder IIIP Rajala, T Liukkonen, M Raitanen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 3, 2011
Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathyJohanna Savikko, Jukka M Rintala, Sini E Rintala, et al.
The Journal of Urology|May 8, 2000
Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancerM P Raitanen, T Marttila, E Kaasinen, et al.
Plastic and Reconstructive Surgery|February 1, 1988
Accelerated tissue expansion with the "overfilling" techniqueJ P Pietilä, R E Nordström, P J Virkkunen, et al.
British Journal of Cancer|August 17, 2001
Prognostic utility of human complement factor H related protein test (the BTA stat Test)M P Raitanen, E Kaasinen, E Rintala, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Intensive Care Medicine|November 23, 2000
Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and the outcomeE Rintala, H Peuravuori, K Pulkki, et al.
International Journal of Cancer|June 17, 1999
Detection of messenger RNA for the beta-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reactionK Hotakainen, S Lintula, J Stenman, et al.
The Journal of Urology|June 1, 1996
Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study GroupP U Malmström, E Rintala, R Wahlqvist, et al.
Journal of Nephrology|October 2, 2015
Epidermal growth factor receptor inhibition with erlotinib ameliorates anti-Thy 1.1-induced experimental glomerulonephritisJukka M Rintala, Johanna Savikko, Sini E Rintala, et al.
Urological Research|January 1, 1992
Cytostatic effect of different strains of Bacillus Calmette-Guérin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alphaP Rajala, E Kaasinen, E Rintala, et al.
The Journal of Urology|March 19, 1999
Transurethral resection with perioperative instilation on interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: a prospective randomized multicenter study--Finnbladder IIIP Rajala, T Liukkonen, M Raitanen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 3, 2011
Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathyJohanna Savikko, Jukka M Rintala, Sini E Rintala, et al.
The Journal of Urology|May 8, 2000
Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancerM P Raitanen, T Marttila, E Kaasinen, et al.
Plastic and Reconstructive Surgery|February 1, 1988
Accelerated tissue expansion with the "overfilling" techniqueJ P Pietilä, R E Nordström, P J Virkkunen, et al.
British Journal of Cancer|August 17, 2001
Prognostic utility of human complement factor H related protein test (the BTA stat Test)M P Raitanen, E Kaasinen, E Rintala, et al.
Pageof 9